Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.5 USD | -2.64% |
|
-5.91% | +47.21% |
May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.21% | 1.64B | |
+18.26% | 124B | |
+17.73% | 111B | |
-12.08% | 23.17B | |
+5.07% | 22.94B | |
-39.94% | 17.42B | |
-10.72% | 17.42B | |
-14.97% | 16.9B | |
+2.76% | 13.71B | |
+25.61% | 11.82B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Top Midday Decliners